p27KIP1: androgen regulation and prognostic significance in prostate cancer.
Loda
M
M
Department of adult oncology, Dana Farber Cancer Institute and Pathology, Brigham and Women's Hospital, Harvard Medical School, USA.
D000728:Androgens / Q000502:physiology*; D018797:Cell Cycle Proteins / Q000378:metabolism / Q000502:physiology*; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors; D003546:Cysteine Endopeptidases / Q000502:physiology; D006801:Humans; D008297:Male; D009097:Multienzyme Complexes / Q000502:physiology; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000503:physiopathology; D046988:Proteasome Endopeptidase Complex; D025521:Tumor Suppressor Proteins; D014452:Ubiquitins / Q000502:physiology
D000728:Androgens; D018797:Cell Cycle Proteins; D009097:Multienzyme Complexes; D025521:Tumor Suppressor Proteins; D014452:Ubiquitins; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex